METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT
Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing....
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SCHRYER BRENDA MURPHY PATRICIA D RABIN MARK B YOSHIKAWA MATTHEW OLSON SHERI J PARK MICHAEL ESKANDARI TARA JACKSON GEOFFREY M WHITE MARGA B |
description | Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2014302494A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2014302494A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2014302494A93</originalsourceid><addsrcrecordid>eNrjZDD2dQ3x8HdR8HdTcPRz9ImM8vRzV3BUcApydjRScHf1c1Xw9APyPUJ9Hf0UgkOdvFydQ3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYmxgZGJpYmjpTFxqgDfdCdG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><source>esp@cenet</source><creator>SCHRYER BRENDA ; MURPHY PATRICIA D ; RABIN MARK B ; YOSHIKAWA MATTHEW ; OLSON SHERI J ; PARK MICHAEL ; ESKANDARI TARA ; JACKSON GEOFFREY M ; WHITE MARGA B</creator><creatorcontrib>SCHRYER BRENDA ; MURPHY PATRICIA D ; RABIN MARK B ; YOSHIKAWA MATTHEW ; OLSON SHERI J ; PARK MICHAEL ; ESKANDARI TARA ; JACKSON GEOFFREY M ; WHITE MARGA B</creatorcontrib><description>Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141009&DB=EPODOC&CC=US&NR=2014302494A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141009&DB=EPODOC&CC=US&NR=2014302494A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHRYER BRENDA</creatorcontrib><creatorcontrib>MURPHY PATRICIA D</creatorcontrib><creatorcontrib>RABIN MARK B</creatorcontrib><creatorcontrib>YOSHIKAWA MATTHEW</creatorcontrib><creatorcontrib>OLSON SHERI J</creatorcontrib><creatorcontrib>PARK MICHAEL</creatorcontrib><creatorcontrib>ESKANDARI TARA</creatorcontrib><creatorcontrib>JACKSON GEOFFREY M</creatorcontrib><creatorcontrib>WHITE MARGA B</creatorcontrib><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><description>Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD2dQ3x8HdR8HdTcPRz9ImM8vRzV3BUcApydjRScHf1c1Xw9APyPUJ9Hf0UgkOdvFydQ3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBoYmxgZGJpYmjpTFxqgDfdCdG</recordid><startdate>20141009</startdate><enddate>20141009</enddate><creator>SCHRYER BRENDA</creator><creator>MURPHY PATRICIA D</creator><creator>RABIN MARK B</creator><creator>YOSHIKAWA MATTHEW</creator><creator>OLSON SHERI J</creator><creator>PARK MICHAEL</creator><creator>ESKANDARI TARA</creator><creator>JACKSON GEOFFREY M</creator><creator>WHITE MARGA B</creator><scope>EVB</scope></search><sort><creationdate>20141009</creationdate><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><author>SCHRYER BRENDA ; MURPHY PATRICIA D ; RABIN MARK B ; YOSHIKAWA MATTHEW ; OLSON SHERI J ; PARK MICHAEL ; ESKANDARI TARA ; JACKSON GEOFFREY M ; WHITE MARGA B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2014302494A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHRYER BRENDA</creatorcontrib><creatorcontrib>MURPHY PATRICIA D</creatorcontrib><creatorcontrib>RABIN MARK B</creatorcontrib><creatorcontrib>YOSHIKAWA MATTHEW</creatorcontrib><creatorcontrib>OLSON SHERI J</creatorcontrib><creatorcontrib>PARK MICHAEL</creatorcontrib><creatorcontrib>ESKANDARI TARA</creatorcontrib><creatorcontrib>JACKSON GEOFFREY M</creatorcontrib><creatorcontrib>WHITE MARGA B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHRYER BRENDA</au><au>MURPHY PATRICIA D</au><au>RABIN MARK B</au><au>YOSHIKAWA MATTHEW</au><au>OLSON SHERI J</au><au>PARK MICHAEL</au><au>ESKANDARI TARA</au><au>JACKSON GEOFFREY M</au><au>WHITE MARGA B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT</title><date>2014-10-09</date><risdate>2014</risdate><abstract>Five novel DNA and protein sequences have been determined for the BRCA2 gene, as have been ten polymorphic sites and their rates of occurrence in the normal alleles of BRCA2. The sequences BRCA2(omi 1-5) and the ten polymorphic sites will provide greater accuracy and reliability for genetic testing. One skilled in the art will be better able to avoid misinterpretations of changes in the gene and/or protein sequence, determine the presence of a normal sequence, and of mutations of BRCA2. This invention is also related to a method of performing gene therapy with BRCA2(omi 1-5) coding sequences or fragments thereof. This invention is further related to protein therapy with BRCA2(omi 1-5) proteins or their functional equivalents.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2014302494A9 |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS VINEGAR WINE |
title | METHOD OF ANALYZING A BRCA2 GENE IN A HUMAN SUBJECT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T15%3A01%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHRYER%20BRENDA&rft.date=2014-10-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2014302494A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |